Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-07-01

EMA Authorised: Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) (tenofovir disoproxil) — Viatris Limited

View source ↗

Summary

Authorised status for Tenofovir disoproxil Viatris (tenofovir disoproxil) by Viatris Limited for HIV infections in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir disoproxil Viatris (tenofovir disoproxil)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 26/06/2026